Wednesday, July 13, 2005

Neonatal withdrawal from maternal volatile substance abuse


M Tenenbein, OG Casiro, MM Seshia and VD Debooy Department of Pediatrics, University of Manitoba.

A study to determine whether neonates born to mothers who are volatile substance abusers are at risk for an abstinence syndrome suggested that there is an identifiable neonatal volatile substance abuse abstinence syndrome. The characteristic chemical odour in the neonate or mother is a marker for its occurrence, and phenobarbital treatment seems to be effective. The Finnegan Scoring System seems to be useful for grading its severity.